Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 69Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ATHENA

02 7KOWA PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2040-09-01

TRAMADOL HYDROCHLORIDE

US Patent Number : 11103452

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214044

Patent Use Code : U-3197

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-09-01

Athena Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2040-09-01

TRAMADOL HYDROCHLORIDE

US Patent Number : 11752103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214044

Patent Use Code : U-3197

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-09-01

Athena Company Banner

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 10238668

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213426

Patent Use Code : U-3244

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 10548909

Drug Substance Claim :

Drug Product Claim :

Application Number : 213426

Patent Use Code : U-3244

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 11478488

Drug Substance Claim :

Drug Product Claim :

Application Number : 213426

Patent Use Code : U-3244

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 8846744

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213426

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-06-03

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 9012440

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213426

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 10245276

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213426

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

CELECOXIB; TRAMADOL HYDROCHLORIDE

US Patent Number : 8598152

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213426

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank